Capture and enrichment of CD34-positive haematopoietic stem and progenitor cells from blood circulation using P-selectin in an implantable device
2008

Capturing Stem Cells from Blood Using P-Selectin

Sample size: 47 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wojciechowski Joel C, Narasipura Srinivas D, Charles Nichola, Mickelsen Deanne, Rana Kuldeeepsinh, Blair Martha L, King Michael R

Primary Institution: Department of Biomedical Engineering, University of Rochester

Hypothesis

Can P-selectin be used to capture and enrich haematopoietic stem and progenitor cells (HSPCs) directly from circulating blood in vivo?

Conclusion

The study demonstrated that P-selectin can effectively capture and enrich HSPCs from blood, achieving a sevenfold increase in purity compared to whole blood.

Supporting Evidence

  • The captured HSPCs showed a sevenfold enrichment over levels found in whole blood.
  • Viable cells were able to differentiate into burst-forming units.
  • Robust cell capture was demonstrated in devices implanted for 2 hours.

Takeaway

Scientists found a way to catch special blood cells that help make new blood using a sticky protein called P-selectin, which could help cancer patients.

Methodology

Rats had vascular shunt prototypes coated with P-selectin implanted into their femoral artery to capture HSPCs from circulating blood.

Potential Biases

Potential bias in the selection of the animal model and the specific conditions under which the experiments were conducted.

Limitations

The study was conducted in rats, and the applicability to human subjects remains to be validated.

Participant Demographics

Adult male Sprague-Dawley rats, average body weight 331 ± 6.2 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1111/j.1365-2141.2007.06967.x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication